FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Hyde

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Procedures

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Living Beings

Physiology

Co-author Network

Publications

TOP 3
Kimberly J Jenko; Sami S Zoghbi; Kacey B Anderson; Amy Deep-Soboslay; Ioline D Henter; Jussi Hirvonen; Thomas M Hyde; Robert B Innis; Joel E Kleinman
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia.
Amanda J Law; Barbara K Lipska; Patricio O'Donnell; Francesco Papaleo; Patrick Piantadosi; Yoshitatsu Sei; Richard E Straub; Craig J Thomas; Radhakrishna Vakkalanka; Yanhong Wang; Aaron D Besterman; Paul J Harrison; Wenwei Huang; Thomas M Hyde; Joel E Kleinman; Daniel R Weinberger
Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
Ran Tao; Daniel R Weinberger; Tianzhang Ye; Mary M Herman; Joel E Kleinman; Chao Li; Barbara K Lipska; Erin N Newburn; Thomas M Hyde
Transcript-specific associations of SLC12A5 (KCC2) in human prefrontal cortex with development, schizophrenia, and affective disorders.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Hyde (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Kimberly J Jenko; Sami S Zoghbi; Kacey B Anderson; Amy Deep-Soboslay; Ioline D Henter; Jussi Hirvonen; Thomas M Hyde; Robert B Innis; Joel E Kleinman
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia.
Schizophrenia research 2012;141(2-3):185-8.
2012: Amanda J Law; Barbara K Lipska; Patricio O'Donnell; Francesco Papaleo; Patrick Piantadosi; Yoshitatsu Sei; Richard E Straub; Craig J Thomas; Radhakrishna Vakkalanka; Yanhong Wang; Aaron D Besterman; Paul J Harrison; Wenwei Huang; Thomas M Hyde; Joel E Kleinman; Daniel R Weinberger
Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(30):12165-70.
2012: Ran Tao; Daniel R Weinberger; Tianzhang Ye; Mary M Herman; Joel E Kleinman; Chao Li; Barbara K Lipska; Erin N Newburn; Thomas M Hyde
Transcript-specific associations of SLC12A5 (KCC2) in human prefrontal cortex with development, schizophrenia, and affective disorders.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2012;32(15):5216-22.
2012: Shusuke Numata; Ran Tao; Daniel R Weinberger; Michael Wininger; Tianzhang Ye; Carlo Colantuoni; Xavier Guitart-Navarro; Thomas M Hyde; Joel E Kleinman; Barbara K Lipska
DNA methylation signatures in development and aging of the human prefrontal cortex.
American journal of human genetics 2012;90(2):260-72.
2012: Lindsay A Bliss; Josh G Chenoweth; Amy Deep-Soboslay; Andrew E Jaffe; Amritha Jaishankar; Joel E Kleinman; Renee F Ren-Patterson; Malik R Sams; Thomas M Hyde
Use of postmortem human dura mater and scalp for deriving human fibroblast cultures.
PloS one 2012;7(9):e45282.
2011: Carlo Colantuoni; ELIZABETH COLANTUONI; Abdel G Elkahloun; Mary M Herman; Thomas M Hyde; Jeffrey T Leek; Barbara K Lipska; Ran Tao; Daniel R Weinberger; Tianzhang Ye; Joel E Kleinman
Temporal dynamics and genetic control of transcription in the human prefrontal cortex.
Nature 2011;478(7370):519-23.
2011: Thomas M Hyde; Towhid Ali; Llewellyn B Bigelow; Carlo Colantuoni; Mary M Herman; Amanda J Law; Barbara K Lipska; Shiny V Mathew; Ochuko E Metitiri; Richard E Straub; Daniel R Weinberger; Tianzhang Ye; Joel E Kleinman
Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31(30):11088-95.
2011: Fengyu Zhang; Qiang Chen; Tianzhang Ye; Barbara K Lipska; Richard E Straub; Radhakrishna Vakkalanka; Dan Rujescu; David St Clair; Thomas M Hyde; Llewellyn B Bigelow; Joel E Kleinman; Daniel R Weinberger
Evidence of sex-modulated association of ZNF804A with schizophrenia.
Biological psychiatry 2011;69(10):914-7.
2011: Joel E Kleinman; Amanda J Law; Barbara K Lipska; Thomas M Hyde; Justin K Ellis; Paul J Harrison; Daniel R Weinberger
Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains.
Biological psychiatry 2011;69(2):140-5.
2011: Amy Deep-Soboslay; Francine M Benes; Vahram Haroutunian; Justin K Ellis; Joel E Kleinman; Thomas M Hyde
Psychiatric brain banking: three perspectives on current trends and future directions.
Biological psychiatry 2011;69(2):104-12.
2010: Amy Deep-Soboslay; Thomas M Hyde; Joseph Callicott; Marc S Lener; Beth A Verchinski; José A Apud; Daniel R Weinberger; Brita Elvevåg
Handedness, heritability, neurocognition and brain asymmetry in schizophrenia.
Brain : a journal of neurology 2010;133(10):3113-22.
2010: Kristin L Bigos; Venkata S Mattay; Joseph Callicott; Richard E Straub; Radhakrishna Vakkalanka; Bhaskar S Kolachana; Thomas M Hyde; Barbara K Lipska; Joel E Kleinman; Daniel R Weinberger
Genetic variation in CACNA1C affects brain circuitries related to mental illness.
Archives of general psychiatry 2010;67(9):939-45.
2010: Wee-Tin Kao; Yanhong Wang; Joel E Kleinman; Barbara K Lipska; Thomas M Hyde; Daniel R Weinberger; Amanda J Law
Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(35):15619-24.
2010: Herve Lemaitre; Venkata S Mattay; Fabio Sambataro; Beth A Verchinski; Richard E Straub; Joseph Callicott; Raja Kittappa; Thomas M Hyde; Barbara K Lipska; Joel E Kleinman; Ronald McKay; Daniel R Weinberger
Genetic variation in FGF20 modulates hippocampal biology.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010;30(17):5992-7.
2009: Kenji Nakata; Barbara K Lipska; Thomas M Hyde; Tianzhang Ye; Erin N Newburn; Yukitaka Morita; Radhakrishna Vakkalanka; Maxim Barenboim; Yoshitatsu Sei; Daniel R Weinberger; Joel E Kleinman
DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(37):15873-8.
2009: Stephen J Huffaker; Jingshan Chen; Kristin K Nicodemus; Fabio Sambataro; Feng Yang; Venkata S Mattay; Barbara K Lipska; Thomas M Hyde; Jian Song; Dan Rujescu; Ina Giegling; Karine Mayilyan; Morgan J Proust; Armen Soghoyan; Grazia Caforio; Joseph Callicott; Alessandro Bertolino; Andreas Meyer-Lindenberg; Jay Chang; Yuanyuan Ji; Michael Egan; Terry Goldberg; Joel E Kleinman; Bai Lu; Daniel R Weinberger
A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia.
Nature medicine 2009;15(5):509-18.
2008: Amy Deep-Soboslay; Bianca Iglesias; Thomas M Hyde; Llewelyn B Bigelow; Vesna Imamovic; Mary M Herman; Joel E Kleinman
Evaluation of tissue collection for postmortem studies of bipolar disorder.
Bipolar disorders 2008;10(7):822-8.
2008: Subroto Ghose; Jeremy M Crook; Cynthia L Bartus; Thomas G Sherman; Mary M Herman; Thomas M Hyde; Joel E Kleinman; Mayada Akil
Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.
The International journal of neuroscience 2008;118(11):1609-27.
2008: Leah J Sartorius; Daniel R Weinberger; Thomas M Hyde; Paul J Harrison; Joel E Kleinman; Barbara K Lipska
Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(11):2626-34.
2008: Thomas M Hyde; Amy Deep-Soboslay; Bianca Iglesias; Joseph Callicott; James M Gold; Andreas Meyer-Lindenberg; Robyn A Honea; Llewellyn B Bigelow; Michael Egan; Esther M Emsellem; Daniel R Weinberger
Enuresis as a premorbid developmental marker of schizophrenia.
Brain : a journal of neurology 2008;131(Pt 9):2489-98.
2008: Carlo Colantuoni; Thomas M Hyde; Shruti Mitkus; Andrew Joseph; Leah Sartorius; Claudia Aguirre; Johanna Creswell; ELIZABETH COLANTUONI; Amy Deep-Soboslay; Mary M Herman; Barbara K Lipska; Daniel R Weinberger; Joel E Kleinman
Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex.
Brain structure & function 2008;213(1-2):255-71.
2008: Nader D Halim; Barbara K Lipska; Thomas M Hyde; Amy Deep-Soboslay; E Michael Saylor; Mary M Herman; Jay Thakar; Ajay Verma; Joel E Kleinman
Increased lactate levels and reduced pH in postmortem brains of schizophrenics: medication confounds.
Journal of neuroscience methods 2008;169(1):208-13.
2008: Elin Lehrmann; Zoan R Afanador; Amy Deep-Soboslay; Gloria Gallegos; William D Darwin; Ross H Lowe; Allan J Barnes; Marilyn A Huestis; Jean L Cadet; Mary M Herman; Thomas M Hyde; Joel E Kleinman; William J Freed
Postmortem diagnosis and toxicological validation of illicit substance use.
Addiction biology 2008;13(1):105-17.
2008: Shruti N Mitkus; Thomas M Hyde; Radhakrishna Vakkalanka; Bhaskar S Kolachana; Daniel R Weinberger; Joel E Kleinman; Barbara K Lipska
Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia.
Schizophrenia research 2008;98(1-3):129-38.
2008: Cynthia Shannon Weickert; Debora A Rothmond; Thomas M Hyde; Joel E Kleinman; Richard E Straub
Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients.
Schizophrenia research 2008;98(1-3):105-10.
2007: Shiny V Mathew; Amanda J Law; Barbara K Lipska; Martha I Dávila-García; Eduardo D Zamora; Shruti N Mitkus; Radhakrishna Vakkalanka; Richard E Straub; Daniel R Weinberger; Joel E Kleinman; Thomas M Hyde
Alpha7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1.
Human molecular genetics 2007;16(23):2921-32.
2007: Thomas M Hyde; Terry Goldberg; Michael Egan; Marc C Lener; Daniel R Weinberger
Frontal release signs and cognition in people with schizophrenia, their siblings and healthy controls.
The British journal of psychiatry : the journal of mental science 2007;191():120-5.
2006: Barbara K Lipska; Amy Deep-Soboslay; Cynthia Shannon Weickert; Thomas M Hyde; Catherine E Martin; Mary M Herman; Joel E Kleinman
Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia.
Biological psychiatry 2006;60(6):650-8.
2006: Barbara K Lipska; Shruti N Mitkus; Mark Caruso; Thomas M Hyde; Jingshan Chen; Radhakrishna Vakkalanka; Richard E Straub; Daniel R Weinberger; Joel E Kleinman
RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity.
Human molecular genetics 2006;15(18):2804-12.
2006: Amanda J Law; Barbara K Lipska; Cynthia Shannon Weickert; Thomas M Hyde; Richard E Straub; Ryota Hashimoto; Paul J Harrison; Joel E Kleinman; Daniel R Weinberger
Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(17):6747-52.
2006: Barbara K Lipska; Tricia Peters; Thomas M Hyde; Nader D Halim; Cara Horowitz; Shruti N Mitkus; Cynthia Shannon Weickert; Mitsuyuki Matsumoto; Akira Sawa; Richard E Straub; Radhakrishna Vakkalanka; Mary M Herman; Daniel R Weinberger; Joel E Kleinman
Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs.
Human molecular genetics 2006;15(8):1245-58.
2006: Ross H Lowe; Allan J Barnes; Elin Lehrmann; William J Freed; Joel E Kleinman; Thomas M Hyde; Mary M Herman; Marilyn A Huestis
A validated positive chemical ionization GC/MS method for the identification and quantification of amphetamine, opiates, cocaine, and metabolites in human postmortem brain.
Journal of mass spectrometry : JMS 2006;41(2):175-84.
2006: Elin Lehrmann; Carlo Colantuoni; Amy Deep-Soboslay; Kevin G Becker; Ross Lowe; Marilyn A Huestis; Thomas M Hyde; Joel E Kleinman; William J Freed
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.
PloS one 2006;1():e114.
2006: Barbara K Lipska; Shruti N Mitkus; Shiny V Mathew; Robert J Fatula; Thomas M Hyde; Daniel R Weinberger; Joel E Kleinman
Functional genomics in postmortem human brain: abnormalities in a DISC1 molecular pathway in schizophrenia.
Dialogues in clinical neuroscience 2006;8(3):353-7.
2005: Daphne J Holt; Susan E Bachus; Thomas M Hyde; Michael Wittie; Mary M Herman; Mark Vangel; Clifford B Saper; Joel E Kleinman
Reduced density of cholinergic interneurons in the ventral striatum in schizophrenia: an in situ hybridization study.
Biological psychiatry 2005;58(5):408-16.
2005: Mitsuyuki Matsumoto; Senda Beltaifa; Cynthia Shannon Weickert; Mary M Herman; Thomas M Hyde; Richard C Saunders; Barbara K Lipska; Daniel R Weinberger; Joel E Kleinman
A conserved mRNA expression profile of SREB2 (GPR85) in adult human, monkey, and rat forebrain.
Brain research. Molecular brain research 2005;138(1):58-69.
2005: Cynthia Shannon Weickert; Davinna L Ligons; T Romanczyk; G Ungaro; Thomas M Hyde; Mary M Herman; Daniel R Weinberger; Joel E Kleinman
Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia.
Molecular psychiatry 2005;10(7):637-50.
2005: William R Perlman; Mitsuyuki Matsumoto; Senda Beltaifa; Thomas M Hyde; Richard C Saunders; Maree Webster; David Rubinow; Joel E Kleinman; Cynthia Shannon Weickert
Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex.
Neuroscience 2005;134(1):81-95.
2005: Cynthia Shannon Weickert; D A Kittell; Richard C Saunders; Mary M Herman; R A Horlick; Joel E Kleinman; Thomas M Hyde
Basic fibroblast growth factor and fibroblast growth factor receptor-1 in the human hippocampal formation.
Neuroscience 2005;131(1):219-33.
2005: Amy Deep-Soboslay; Mayada Akil; Catherine E Martin; Llewellyn B Bigelow; Mary M Herman; Thomas M Hyde; Joel E Kleinman
Reliability of psychiatric diagnosis in postmortem research.
Biological psychiatry 2005;57(1):96-101.
2004: Jingshan Chen; Barbara K Lipska; Nader D Halim; Quang D Ma; Mitsuyuki Matsumoto; Samer Melhem; Bhaskar S Kolachana; Thomas M Hyde; Mary M Herman; José A Apud; Michael Egan; Joel E Kleinman; Daniel R Weinberger
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain.
American journal of human genetics 2004;75(5):807-21.
2004: Amanda J Law; Cynthia Shannon Weickert; Thomas M Hyde; Joel E Kleinman; Paul J Harrison
Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines.
The American journal of psychiatry 2004;161(10):1848-55.
2004: Michael Egan; Richard E Straub; Terry Goldberg; Imtiaz Yakub; Joseph Callicott; Ahmad R Hariri; Venkata S Mattay; Alessandro Bertolino; Thomas M Hyde; Cynthia Shannon Weickert; Mayada Akil; Jeremy Crook; Radhakrishna Vakkalanka; Rishi Balkissoon; Richard A Gibbs; Joel E Kleinman; Daniel R Weinberger
Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(34):12604-9.
2004: Cynthia Shannon Weickert; Richard E Straub; Benjamin W McClintock; Mitsuyuki Matsumoto; Ryota Hashimoto; Thomas M Hyde; Mary M Herman; Daniel R Weinberger; Joel E Kleinman
Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
Archives of general psychiatry 2004;61(6):544-55.
2004: Marquis P Vawter; Cynthia Shannon Weickert; Erick Ferran; Mitsuyuki Matsumoto; Kevin Overman; Thomas M Hyde; Daniel R Weinberger; William E Bunney; Joel E Kleinman
Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia.
Neurochemical research 2004;29(6):1245-55.
2004: R Hashimoto; Richard E Straub; Cynthia Shannon Weickert; Thomas M Hyde; Joel E Kleinman; Daniel R Weinberger
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia.
Molecular psychiatry 2004;9(3):299-307.
2004: Amanda J Law; Cynthia Shannon Weickert; Thomas M Hyde; Joel E Kleinman; Paul J Harrison
Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain.
Neuroscience 2004;127(1):125-36.
2004: Subroto Ghose; Cynthia Shannon Weickert; Sarah M Colvin; Joseph T Coyle; Mary M Herman; Thomas M Hyde; Joel E Kleinman
Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(1):117-25.
2003: Nader D Halim; Cynthia Shannon Weickert; Benjamin W McClintock; Thomas M Hyde; Daniel R Weinberger; Joel E Kleinman; Barbara K Lipska
Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development.
Molecular psychiatry 2003;8(9):797-810.
2003: Elin Lehrmann; Thomas M Hyde; Marquis P Vawter; Kevin G Becker; Joel E Kleinman; William J Freed
The use of microarrays to characterize neuropsychiatric disorders: postmortem studies of substance abuse and schizophrenia.
Current molecular medicine 2003;3(5):437-46.
2003: Mitsuyuki Matsumoto; Cynthia Shannon Weickert; Senda Beltaifa; Bhaskar S Kolachana; Jingshan Chen; Thomas M Hyde; Mary M Herman; Daniel R Weinberger; Joel E Kleinman
Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(8):1521-30.
2003: Cynthia Shannon Weickert; Thomas M Hyde; Barbara K Lipska; Mary M Herman; Daniel R Weinberger; Joel E Kleinman
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia.
Molecular psychiatry 2003;8(6):592-610.
2003: Mayada Akil; Bhaskar S Kolachana; Debora A Rothmond; Thomas M Hyde; Daniel R Weinberger; Joel E Kleinman
Catechol-O-methyltransferase genotype and dopamine regulation in the human brain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(6):2008-13.
2003: Elin Lehrmann; Jonathan M Oyler; Marquis P Vawter; Thomas M Hyde; Bhaskar S Kolachana; Joel E Kleinman; Marilyn A Huestis; Kevin G Becker; William J Freed
Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse.
The pharmacogenomics journal 2003;3(1):27-40.
2003: Mitsuyuki Matsumoto; Cynthia Shannon Weickert; Mayada Akil; Barbara K Lipska; Thomas M Hyde; Mary M Herman; Joel E Kleinman; Daniel R Weinberger
Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function.
Neuroscience 2003;116(1):127-37.
2002: Marquis P Vawter; Jeremy M Crook; Thomas M Hyde; Joel E Kleinman; Daniel R Weinberger; Kevin G Becker; William J Freed
Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study.
Schizophrenia research 2002;58(1):11-20.
2002: Alessandro Tessitore; Ahmad R Hariri; Francesco Fera; William G Smith; Thomas N Chase; Thomas M Hyde; Daniel R Weinberger; Venkata S Mattay
Dopamine modulates the response of the human amygdala: a study in Parkinson's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(20):9099-103.
2002: Emad H Hamid; Thomas M Hyde; Michael Egan; Steve S Wolf; Mary M Herman; Charles Nemeroff; Joel E Kleinman
Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders.
Biological psychiatry 2002;51(10):795-800.
2002: Venkata S Mattay; Alessandro Tessitore; Joseph Callicott; Alessandro Bertolino; Terry Goldberg; Thomas N Chase; Thomas M Hyde; Daniel R Weinberger
Dopaminergic modulation of cortical function in patients with Parkinson's disease.
Annals of neurology 2002;51(2):156-64.
2002: Marquis P Vawter; L Thatcher; N Usen; Thomas M Hyde; Joel E Kleinman; William J Freed
Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.
Molecular psychiatry 2002;7(6):571-8.
2002: Jeremy M Crook; Mayada Akil; B C W Law; Thomas M Hyde; Joel E Kleinman
Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects.
Molecular psychiatry 2002;7(2):157-64.
2001: Michael Egan; Thomas M Hyde; J B Bonomo; Venkata S Mattay; Llewellyn B Bigelow; Terry Goldberg; Daniel R Weinberger
Relative risk of neurological signs in siblings of patients with schizophrenia.
The American journal of psychiatry 2001;158(11):1827-34.
2001: Michael Egan; Terry Goldberg; Tonya Gscheidle; M Weirich; Robert R Rawlings; Thomas M Hyde; Llewellyn B Bigelow; Daniel R Weinberger
Relative risk for cognitive impairments in siblings of patients with schizophrenia.
Biological psychiatry 2001;50(2):98-107.
2001: Thomas M Hyde; Jeremy M Crook
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
Journal of chemical neuroanatomy 2001;22(1-2):53-63.
2001: Maree Webster; Cynthia Shannon Weickert; M M Herman; Thomas M Hyde; Joel E Kleinman
Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia.
Schizophrenia research 2001;49(1-2):89-98.
2001: J Thomas Noga; Thomas M Hyde; Susan E Bachus; M M Herman; Joel E Kleinman
AMPA receptor binding in the dorsolateral prefrontal cortex of schizophrenics and controls.
Schizophrenia research 2001;48(2-3):361-3.
2001: Cynthia Shannon Weickert; Maree Webster; Thomas M Hyde; Mary M Herman; Susan E Bachus; G Bali; Daniel R Weinberger; Joel E Kleinman
Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia.
Cerebral cortex (New York, N.Y. : 1991) 2001;11(2):136-47.
2000: Cynthia Shannon Weickert; Maree Webster; S M Colvin; Mary M Herman; Thomas M Hyde; Daniel R Weinberger; Joel E Kleinman
Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone.
The Journal of comparative neurology 2000;423(3):359-72.
2000: C M Bower; Thomas M Hyde; M Zaka; Emad H Hamid; Serapio Baca; Michael Egan
Decreased mu-opioid receptor binding in the globus pallidus of rats treated with chronic haloperidol.
Psychopharmacology 2000;150(3):260-3.
1999: Chris F Spurney; Serapio Baca; A M Murray; george jaskiw; Joel E Kleinman; Thomas M Hyde
Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats.
Synapse (New York, N.Y.) 1999;34(4):266-76.
1999: Marquis P Vawter; A L Howard; Thomas M Hyde; Joel E Kleinman; William J Freed
Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia.
Molecular psychiatry 1999;4(5):467-75.
1999: Daphne J Holt; Mary M Herman; Thomas M Hyde; Joel E Kleinman; Christopher M Sinton; Dwight C German; Louis B Hersh; Ann M Graybiel; Clifford B Saper
Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia.
Neuroscience 1999;94(1):21-31.
1998: Marquis P Vawter; JJ Hemperly; Thomas M Hyde; Susan E Bachus; Dale VanderPutten; A L Howard; H E Cannon-Spoor; Michael T McCoy; Maree Webster; Joel E Kleinman; William J Freed
VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophrenia.
Experimental neurology 1998;154(1):1-11.
1998: Andreas Heinz; Michael B Knable; S S Wolf; Douglas W Jones; Julia G Gorey; Thomas M Hyde; Daniel R Weinberger
Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity.
Neurology 1998;51(4):1069-74.
1998: Serapio Baca; Barbara K Lipska; Michael Egan; Susan E Bachus; J N Ferguson; Thomas M Hyde
Effects of prefrontal cortical lesions on neuropeptide and dopamine receptor gene expression in the striatum-accumbens complex.
Brain research 1998;797(1):55-64.
1998: Emad H Hamid; Thomas M Hyde; Serapio Baca; Michael Egan
Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia.
Brain research 1998;796(1-2):291-5.
1998: Marquis P Vawter; H E Cannon-Spoor; JJ Hemperly; Thomas M Hyde; Dale VanderPutten; Joel E Kleinman; William J Freed
Abnormal expression of cell recognition molecules in schizophrenia.
Experimental neurology 1998;149(2):424-32.
1997: LS Krimer; Mary M Herman; Richard C Saunders; James C Boyd; Thomas M Hyde; J M Carter; Joel E Kleinman; Daniel R Weinberger
A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia.
Cerebral cortex (New York, N.Y. : 1991) 1997;7(8):732-9.
1997: LS Krimer; Thomas M Hyde; Mary M Herman; Richard C Saunders
The entorhinal cortex: an examination of cyto- and myeloarchitectonic organization in humans.
Cerebral cortex (New York, N.Y. : 1991) 1997;7(8):722-31.
1997: J Thomas Noga; Thomas M Hyde; M M Herman; Chris F Spurney; Llewellyn B Bigelow; Daniel R Weinberger; Joel E Kleinman
Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains.
Synapse (New York, N.Y.) 1997;27(3):168-76.
1997: Y L Hurd; Mary M Herman; Thomas M Hyde; Llewellyn B Bigelow; Daniel R Weinberger; Joel E Kleinman
Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects.
Molecular psychiatry 1997;2(6):495-500.
1997: Susan E Bachus; Thomas M Hyde; Mary M Herman; Michael Egan; Joel E Kleinman
Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics.
Journal of psychiatric research 1997;31(2):233-56.
1996: Michael B Knable; Thomas M Hyde; A M Murray; M M Herman; Joel E Kleinman
A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls.
Biological psychiatry 1996;40(12):1191-9.
1996: Thomas M Hyde; Michael B Knable; A M Murray
Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex.
Synapse (New York, N.Y.) 1996;24(3):224-32.
1996: Michael Egan; Y Hurd; J Ferguson; Susan E Bachus; E H Hamid; Thomas M Hyde
Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
Psychopharmacology 1996;127(4):337-45.
1996: S S Wolf; Douglas W Jones; Michael B Knable; Julia G Gorey; Kan S Lee; Thomas M Hyde; Richard Coppola; Daniel R Weinberger
Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding.
Science (New York, N.Y.) 1996;273(5279):1225-7.
1995: Michael B Knable; Douglas W Jones; Richard Coppola; Thomas M Hyde; Kan S Lee; Julia G Gorey; Daniel R Weinberger
Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1216-25.
1995: Thomas M Hyde; M E Stacey; R Coppola; S F Handel; K C Rickler; Daniel R Weinberger
Cerebral morphometric abnormalities in Tourette's syndrome: a quantitative MRI study of monozygotic twins.
Neurology 1995;45(6):1176-82.
1995: A M Murray; Thomas M Hyde; Michael B Knable; M M Herman; L B Bigelow; J M Carter; Daniel R Weinberger; Joel E Kleinman
Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1995;15(3 Pt 2):2186-91.
1995: Thomas M Hyde; Michael Egan; L L Wing; RJ Wyatt; Daniel R Weinberger; Joel E Kleinman
Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.
Psychopharmacology 1995;118(2):142-9.
1995: Thomas M Hyde; Daniel R Weinberger
Tourette's syndrome. A model neuropsychiatric disorder.
JAMA : the journal of the American Medical Association 1995;273(6):498-501.
1995: S S Wolf; Thomas M Hyde; Richard C Saunders; M M Herman; Daniel R Weinberger; J E Kleinman
Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects.
Journal of neural transmission. General section 1995;102(1):55-65.
1995: Michael Egan; Thomas M Hyde; J E Kleinman; RJ Wyatt
Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose.
Psychopharmacology 1995;117(1):74-81.
1994: Michael B Knable; Thomas M Hyde; M M Herman; J M Carter; L Bigelow; Joel E Kleinman
Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients.
Biological psychiatry 1994;36(12):827-35.
1994: Michael Egan; Y Hurd; Thomas M Hyde; Daniel R Weinberger; RJ Wyatt; J E Kleinman
Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.
Synapse (New York, N.Y.) 1994;18(3):178-89.
1994: Elizabeth Cantor-Graae; Thomas F McNeil; K C Rickler; Karin Sjöström; R Rawlings; E S Higgins; Thomas M Hyde
Are neurological abnormalities in well discordant monozygotic co-twins of schizophrenic subjects the result of perinatal trauma?
The American journal of psychiatry 1994;151(8):1194-9.
1994: Thomas M Hyde; H A Emsellem; C Randolph; K C Rickler; Daniel R Weinberger
Electroencephalographic abnormalities in monozygotic twins with Tourette's syndrome.
The British journal of psychiatry : the journal of mental science 1994;164(6):811-7.
1994: Michael B Knable; Thomas M Hyde; Michael Egan; M Tosayali; RJ Wyatt; Joel E Kleinman
Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements.
Brain research 1994;646(2):217-22.
1994: Thomas M Hyde; S Nawroz; Terry Goldberg; L B Bigelow; D Strong; J L Ostrem; Daniel R Weinberger; Joel E Kleinman
Is there cognitive decline in schizophrenia? A cross-sectional study.
The British journal of psychiatry : the journal of mental science 1994;164(4):494-500.
1994: S S Wolf; Thomas M Hyde; Daniel R Weinberger
Malformations of the septum pellucidum: two distinctive cases in association with schizophrenia.
Journal of psychiatry & neuroscience : JPN 1994;19(2):140-4.
1994: D C Ohuoha; Michael B Knable; S S Wolf; Joel E Kleinman; Thomas M Hyde
The subnuclear distribution of 5-HT3 receptors in the human nucleus of the solitary tract and other structures of the caudal medulla.
Brain research 1994;637(1-2):222-6.
1994: S S Wolf; Thomas M Hyde; T W Moody; Richard C Saunders; Daniel R Weinberger; J E Kleinman
Autoradiographic characterization of 125I-neurotensin binding sites in human entorhinal cortex.
Brain research bulletin 1994;35(4):353-8.
1993: C Randolph; Thomas M Hyde; James M Gold; Terry Goldberg; Daniel R Weinberger
Tourette's syndrome in monozygotic twins. Relationship of tic severity to neuropsychological function.
Archives of neurology 1993;50(7):725-8.
1993: S S Wolf; Thomas M Hyde; Daniel R Weinberger
Neurobiology of schizophrenia.
Current opinion in neurology and neurosurgery 1993;6(1):86-92.
1992: Thomas M Hyde; L C Wu; I B Krasnov; S K Sigworth; NG Daunton; F D'Amelio
Quantitative autoradiographic analysis of muscarinic cholinergic and GABAA (benzodiazepine) receptors in the forebrain of rats flown on the Soviet Biosatellite COSMOS 2044.
Brain research 1992;593(2):291-4.
1992: Thomas M Hyde; J C Ziegler; Daniel R Weinberger
Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis.
Archives of neurology 1992;49(4):401-6.
1992: Thomas M Hyde; B A Aaronson; C Randolph; K C Rickler; Daniel R Weinberger
Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins.
Neurology 1992;42(3 Pt 1):652-8.
1991: Thomas M Hyde; J R Hotson; Joel E Kleinman
Differential diagnosis of choreiform tardive dyskinesia.
The Journal of neuropsychiatry and clinical neurosciences 1991;3(3):255-68.